CEACAM5 and colorectal carcinoma: ROC curve analysis confirmed PCAT1 as a promising diagnostic marker for CRC, regardless of CEA status (Fig. 4b; Table 2), indicating that PCAT1 could partly compensate for low CEA levels in CRC diagnosis.